Medtronic's MiniMed 670G - the closest thing yet to ... the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to self-inject basal ...

Medtronic's MiniMed 670G hybrid closed loop system has been hailed as a long-awaited breakthrough, as many people with type 1 diabetes and their families have been calling for such a device for years.

Medtronic plc MDT is scheduled to report third-quarter fiscal 2025 results on Feb. 18, before the opening bell. See the Zacks Earnings Calendar to stay ahead of market-making news. In the last ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Shares of Medtronic (NYSE: MDT) are off to a fantastic start ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and ...

MiniMed 670G and MiniMed 780G (Medtronic); t:slim X2 with Control-IQ technology (Tandem Diabetes Care); CamAPS Fx (CamDiab Ltd.); Diabeloop Generation 1 (DBLG‐1; Diabeloop) and Diabeloop for ...

Shares of Medtronic (NYSE ... And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and automatically adjust insulin ...